陇神戎发公告,控股子公司甘肃普安制药股份有限公司近日取得由甘肃省药品监督管理局核准换发的《药品生产许可证》以及下发的《药品 GMP 符合性检查告知书》。换发后的《药品生产许可证》有效期至2026年3月2日,生产地址和生产范围为甘肃省武威市凉州区黄羊生态工业(食品)示范园农大北路1号,包括合剂、膜剂、原料药(盐酸纳洛酮)、前处理及提取等。普安制药新建的年产5000万盒(3亿支)宣肺止嗽合剂等液体制剂生产线升级改造项目(二期)符合《药品生产质量管理规范》要求并达到投产运营条件,有利于进一步保障宣肺止嗽合剂市场销售及产品供应,对公司未来发展具有积极意义。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.